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1. Introduction 
There is an official history of hypnotism: very often it begins with the Scottish surgeon 
James Braid (1795-1860) who was one of the first physicians to have used this word in 1843. 
Instead of using the standard magnetic induction popularized by magnetism/mesmerism1, 
he proposed his subjects to stare steadily at a shiny object to enter a trance. He tested his 
method to anesthetize his patients during surgeries (Braid, 1843). The practice of hypnosis, 
using deliberate techniques to help focus attention, is recent, but trance states have always 
been part of the human experience. Many kinds of trance phenomena are observed in 
shamanism, fakirism, witchcraft, and religion but also in psychopathology. After remaining 
an inglorious stage practice in western countries, hypnosis has begun to gain relevance in 
                                                 
1There are slight differences between “mesmerism” and “animal magnetism”. Here the label 
“mesmerism” is used as it is more encountered in the USA. In this country as well as in England, a 
secondary current emerged among “magnetizers” in order to remove all practices that they thought 
irrelevant or that did not seem to contribute to the cure. However, both derive from the practice first 
developped by Anton Mesmer (1734-1815) that he himself called “animal magnetism”. For our topic, it 
is refered here to the wide research on “magnetism” that has started later in 1784 with the Marquis de 
Puységur and lasted for more than one century mostly in France and England. Studies and practices 
focused on several main points:  
- the reproduction of (alleged) results obtained under magnetic trance (cures but also various 
phenomena such as blind reading, hyperscience, clear-sightedness...)  
- the definition of the medium (magnetic fluid, suggestion...) causing both trance and phenomena 
- new concepts about the human psyche that these phenomena (if agreed) made necessary. 
The controversy that opposed top physicians, scientists and philosophers, ended at the begining of the 
20th along with the onset of psychoanalysis. All the very interesting results (although discussed) have 
suddenly been swept off. The opponents of magnetism argued that alleged phenomena were either 
caused by gullible practitioners who were abused by their hysterical patients, or originated in 
manipulations performed by charlatans (Meheust, 1999). Meanwhile, the emerging science of hypnosis 
has also been put aside as Freud claimed that results obtained by hypnosis did not last as long as those 
gained in full counsciousness by psychoanalysis... While this field of experimentation was abandonned 
in Europe, it has regained interest after 1950 both in the USA and USSR with parapsychology, in 
particular thanks to the financial support of military agencies: for these latter, new means to obtain 
information or exert an influence were sought. But for scientists, “animal magnetism” is nowadays 
considered an irrelevant matter of interest, perhaps too rapidly. 
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medicine as has proven a real efficiency in several domains; thanks to Milton Erickson 
(1901-1980), it has earned its place as a therapeutic approach in psychology.  
Hypnosis is still at the margins of the scientific mainstream. After the eviction of mesmerism 
and many related phenomena from the list of tolerated experimental fields (Meheust, 1999), 
some effort is still required to limit the description of emergences under trance to something 
acceptable and analyzable. Psychology and medicine seem to have satisfied these criteria in 
their use of hypnosis as sought goals are largely agreed. Although purposes vary widely, 
their experimental fields overlap because of the very nature of hypnosis. They both use 
hypnosis for the benefit of patients. They use some of the same scientific methods, including 
functional imagery and clinical trials or surveys whose design seems sufficient to assure 
confidence in the conclusions. In relation to psychosomatic troubles, medicine and 
psychology share a no man’s land where medical treatment appears insufficient and where 
patient support is necessary (for example pain management). The use of hypnosis consists of 
mild practices that, according to psychologists, are respectful of individuals’ will: these 
range from relaxation techniques coupled with guided imagery and/or suggestions to more 
complex tailored hypnosis where trance can be deeper. Self hypnosis belongs to this group 
of techniques, as it is often encountered in educational/behavioral patient management. No 
discussion will question here the validity of such a grouping of techniques.  
Among medical fields, oncology is a particularly good domain for the use of hypnosis, 
because cancer is typical of the difficult diseases where medicine fails. This chapter reports 
the different trials and investigations that today build the consensus on which the routine 
practice of hypnosis thrives. After hoping for a prognostic impact of hypnosis on cancer 
itself, investigations have changed their target and now focus on alleviating side-effects of 
the disease and/or its treatment. The issues studied concern immunity and treatment 
response. Surveys concentrate on patients’ well-being as well as more specialized topics 
such as anxiety, depression, fatigue, and pain. Very specialized issues, such as hot flushes 
after cancer treatment, are also addressed. 
2. The impact of hypnosis on cancer itself 
2.1 Survival outcomes 
The first trial investigating survival as a main endpoint2 was reported by Newton (1983). 
Unfortunately, the design was inappropriate, as patients were not randomized between the 
treatment conditions (with or without hypnosis). Also, patients who received less than three 
one-hour weekly hypnosis sessions were compared to those receiving at least three. As 
expected, life was shorter for the patients dying before they could receive at least 3 sessions. 
Despite these weaknesses, this investigation launched a long series of prospective research 
on psychosocial interventions, at a rate of about one per year since 1985 (Kwiatkowski, 
2009). Another trial tested hypnosis as the main psychosocial intervention in patients 
diagnosed with melanoma (Walker, 2000), but it contained the same kind of methodological 
flaws, and thus the slight difference in favor of hypnosis could not be trusted. 
                                                 
2Endpoint is often used in this chapter because its meaning differs slightly from the words goal and 
purpose. In clinical research, endpoint is the measurable goal (ex. goal = to live longer; endpoint = 
survival time – goal = to live better; endpoint = score with the quality of life questionnaire) 
www.intechopen.com
 
Hypnosis in Cancer Patients: Can We Do Better? 
 
55 
Four other randomized controlled trials investigated the impact on survival of educational 
supportive interventions (group therapy) including self-hypnosis to help patients handle 
pain or anxiety (Spiegel, 1989; Goodwin, 2001; Kissane, 2007; Spiegel, 2007). Intervention 
consisted of weekly 90 minutes group sessions where women were encouraged to share and 
confront their problems, strengthen their relationships, discuss strategies for coping with 
cancer and find enhanced meaning in their lives. But no suggestion was given to let them 
believe the intervention could increase their odds of survival. Patients were asked to attend 
sessions during one year in parallel with standard cancer treatments. The first trial that 
included only 86 patients with metastatic breast carcinoma, was significant, reducing by 
24% the risk of death (Spiegel, 1989) while median survival time after randomization was 17 
months longer in the intervention group. The three further trials, performed with a similar 
design to confirm this outcome, included respectively 235, 227 and 122 women. 
Unfortunately, they did not show any prognostic advantage for the intervention.  
2.2 Impact on the response to chemotherapy 
The response to chemotherapy is an interesting endpoint because it usually correlates to 
overall survival: the better the tumor regresses, the longer the patient survives (with or 
without relapse/metastasis). Walker et al. (1998, 1999) tested a protocol including relaxation 
training and guided imagery. Before the first course of chemotherapy, patients randomized 
to the test group were taught a relaxation method that consisted of “progressive muscular 
and cue-controlled relaxation” (Hutchings, 1980). The patients were given audiotapes with 
relaxation instructions and asked to look at a portfolio of cartoons to help them imagine 
their immune cells destroying the cancer. They also kept a diary to record their daily 
practice duration. Response to treatment and personal practice was evaluated at the end of 
the chemotherapy. No significant difference in tumor regression was observed between the 
two treatment conditions, although a weak association was found between the vividness of 
imagery and clinical tumor response. 
2.3 Enhancement of immunity 
Immune cells, mainly lymphoid natural killer (NK) cells, play a major role in tumor cell 
lysis, and provoking an immune response is useful in cancer treatment. Immunity is 
probably responsible for the spontaneous complete remissions without treatment observed 
in melanoma, and partial histopathological remissions in breast cancer (Horii, 2005). In 
addition, metastasis are often discovered but no primitive tumor can be identified: this 
suggests that the immune system destroyed the initial tumor cells.  
Immunity can be thought of as another self, connecting the psychic and physical selves, and 
capable of learning and memory (i.e. adaptation). For psychologists, a special property of 
this immune self is that it can be conditioned (Ader, 1993)3, which makes it a target of choice 
                                                 
3Ader's experiment consisted of the combination of an unconditional immune stimulus (the delivery of 
a dose of Cyclosporin) with a neutral stimulus (ex. a colored light, a bell or some food) and the 
repetition of their presentation together. Each time after the Cyclosporin infusion, blood was sampled 
and some immune factors measured: the results showed the expected immune drop. After a certain 
number of iterations, only the neutral stimulus was given, but surprisingly, there was a similar drop in 
immune markers without the use of any drug. Immunity can thus be conditioned. 
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for hypnosis. Hypnosis has already demonstrated a real efficiency against auto-immune 
disease, including allergy and asthma (Hackman, 2000; Langewitz, 2005) with a significant 
decrease of symptoms for patients trained for self-hypnosis. 
However, the immune system is very complex and many different parameters (white cell 
count, cytotoxic potential of NK, cytokines, hormones, cell receptors...) need to be taken into 
account if one wants to discover significant effects. This multiplicity of parameters increases 
the risk of false positive study outcomes. The immune system is also affected by variations 
in gene expression, and this expression can itself be altered by hypnosis (Rossi, 2002). Data 
demonstrate the high level of interaction between biological and psychological functions, 
and it is noteworthy that influences are bi-directional (Kiecolt-Glaser, 1999; Temoshok, 
2002). 
Behavior is another lever that can be used to enhance immunity. As immunity is very 
dependent on circadian rhythms (mainly the activity-sleep cycle) and on the use of 
psychotropic substances (tobacco, alcohol, hypnotics, drugs...), any behavioral change that 
aims to reduce addiction or ameliorate circadian rhythms can benefit immunity. Conversely, 
this probably explains why chronic depression almost doubles cancer risk in the elderly 
(Penninx, 1998) as it generally disturbs sleep. Many kinds of psychosocial intervention 
targeting behavior, such as group relaxation training, meditation, are able to influence 
immunity. Since the immune system appears weak in cancer patients (since mutated cells 
avoid cellular immunity), psychosocial approaches can be proposed to remedy this 
deficiency: hypnosis stands in good place among them. 
A first trial testing a psychiatric intervention (including relaxation training but without 
hypnosis) involved patients with malignant melanoma (Fawzy, 1990). Affective changes 
related to the intervention were correlated to NK levels. Bakke and col. (2002) tested 
longitudinally relaxation plus guided imagery in stage I-II breast cancer patients. After eight 
weeks of training, no change in NK cytotoxicity was observed, but the NK lymphocyte 
fraction increased in parallel to improvements in mood. These results were not sustained 
after a 3-month follow-up. In 2008, Lengacher et al. performed a pilot study using the same 
pretest-posttest design in the same kind of population (28 breast cancer patients aged 25 to 
75 years). NK-cell cytotoxicity was significantly improved four weeks post-surgery. Both 
trials, although of limited sample size, suggest that hypnosis can positively impact the 
immune system. Emotions/mood seemed more correlated to immune changes than coping 
attitudes were: this might be of importance in defining the strategies for suggestions during 
hypnosis sessions. 
3. Hypnosis and patients’ well-being 
As the trials focusing on overall survival turned out negative, new goals for hypnosis have 
been proposed. The main issues now addressed include quality of life, mood, depression, 
anxiety, and of course pain. We review these topics hereafter. 
3.1 Quality of life 
Quality of life (QOL) is an accurately standardized concept developed over the past 3 or 4 
decades. QOL reflects a great variety of parameters among which cancer status, treatments 
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toxicities4, physical and psychosocial dimensions, sexual functioning and even financial 
difficulties. Validated self-questionnaires such as QLQ-C30 (Aaronson, 1993) or SF36 (Wade, 
1992) enable a good evaluation of patients’ QOL in both curative or palliative situations 
except when the disease becomes too severe and end of life is expected. In the latter, 
specialized questionnaires are nowadays available (MV-QOLI (Byock, 1998), Qual-E 
(Steinhauser, 2002)). In palliative situations, QOL is sometimes chosen as surrogate endpoint 
for survival (Methy, 2010). However, QOL questionnaires find some limitations in 
childhood (Payot, 2011), especially with the youngest patients who cannot of course fill out 
questionnaires and with palliative patients who sometimes need the help of a relative or of a 
nurse to answer the questions or write the answers.  
Very interesting research has been performed by Liossi and White (2001) on the impact of 
tailored hypnosis sessions on QOL among 50 terminally ill cancer patients. Intervention 
consisted of four 30 minutes weekly personal hypnosis sessions and it was compared to a 
cognitive-existential support given at the same rhythm. Suggestions were most often made 
in order to help patient manage his predominant symptoms but ego-strengthening 
suggestions were also used, either general or specific. Patients were asked to fill out QOL 
questionnaires (the Rotterdam Symptom Checklist (DeHaes, 1990) and the HADS 
(Zigmond, 1983)) before and after each session. The protocol duration was four weeks. 
Hypnosis demonstrated significant superiority over cognitive-existential management, 
improving QOL scores and reducing depression and anxiety. Other trials included QOL as 
secondary endpoint (Spiegel, 1989, 2007; Goodwin, 2001), and similar benefits in QOL were 
reported. Although QOL is a general and easy to use index, too few trials have focused on it. 
This endpoint should receive more attention in further research. 
3.2 Depression and anxiety 
Sporadic depression moderately increases (by 20%) cancer risk (Dalton, 2002), while chronic 
depression seems to have an even greater impact on this risk (Penninx, 1998). Conversely, 
cancer favors depression, as almost 50% of patients will face this mood disorder during their 
treatment or in the following years (Derogatis, 1983; Morasso, 2001; Harter, 2001). 
Depression causes a lot of personal suffering and should be treated for that sole reason. 
Depression has also been suggested to shorten survival because it reduces treatment 
compliance, but also because it increases the suicide rate (Reich, 2007). Another reason to 
manage depression in cancer patients is that this symptom correlates to poor immune 
response (Lutgendorf, 2008; Steel, 2007) and worse prognosis (Watson, 1999; Hjerl, 2003). 
This makes depression a major target for psychosocial intervention (Spiegel, 2003). 
In the previously cited trials testing the impact on survival of a cognitive-behavioral therapy 
including self-hypnosis, all authors reported a significant positive impact of this 
intervention on depression and anxiety among breast cancer patients. In terminally ill cancer 
patients, Liossi (2001) obtained similar improvements. As cancer survivors may also 
experience depression, Elkins et al. (2008) performed a trial testing the impact of 5 weekly 
sessions of hypnosis plus self-hypnosis training, and observed a significant decrease in 
anxiety and depression scores in the treatment group.  
                                                 
4 Chemotherapy, radiotherapy and even hormonotherapy can induce various side-effects: 
haematological toxicities (mainly destruction of leucocytes), fatigue, nausea, vomiting, loss of appetite, 
hot-flushes, hair loss, skin syndrome, paresthesia... 
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Overall, hypnosis appears to be a good alternative to conventional psychotherapy against 
depression (Alladin, 2007). Very few other non-pharmacologic approaches reach its efficacy, 
although meditation plus yoga showed remission rates comparable to those obtained with a 
combination antidepressants and psychotherapy (Butler, 2008; Kocsis, 2000). This conclusion 
is not surprising, as meditation is another means to alter consciousness and obtain a trance. 
These approaches should thus be tested in cancer patients, where the incidence of 
depression is very high. 
3.3 Pain management 
Milton Erickson (1959) was the first author to report the efficacy of hypnosis against pain in 
cancer patients. Pain should not be considered an isolated symptom of the disease or its 
treatment. Often, pain has a psychosocial dimension in our culture that echoes both social 
loneliness and personal distress (Zaza, 2000). It therefore requires the intervention of skilled 
psychologists. Acute pain should be considered separately as it is often a consequence of 
surgery and may be treated efficiently with analgesic drugs. Two domains are available to 
hypnosis, as analgesic treatment may expose patients to severe side-effects (for example 
respiratory complications): 
- expected pain during invasive medical procedures 
- chronic pain, especially during palliative treatment. 
Several trials have demonstrated the utility of hypnosis to counterbalance anticipated aches 
by children undergoing painful medical procedures such as lumbar puncture or bone 
marrow aspiration. Hypnotic techniques (guided imagery, direct or indirect suggestions) 
applied during medical procedures appeared more efficient than behavioral techniques 
(cognitive-behavioral training, distraction) to reduce fear, anxiety and pain during 
procedures (Zelter, 1982; Katz, 1987; Smith, 1996; Liossi, 1999). In these studies, patients age 
ranged from 3 to 15 and sample size of the trials was around 30. In children, the magnitude 
of the result depends on hypnotizability of these young patients, and switching to self-
hypnosis is less efficient than hypnosis induced by a therapist (Hawkins, 1998; Smith, 1996). 
Butler (2005) tested an interesting hypnosis strategy against pediatric pain when he trained 
children as well as their parents, observing a significant reduction of pain, procedural time 
and thus overall costs thanks to hypnosis. In adults, trials addressing this issue are scarce. 
Montgomery (2002) successfully tested hypnosis to reduce pain and distress in women 
undergoing breast biopsy. This shows that such an approach should be employed more 
frequently, instead of assuming that adults are able to manage the transient pain induced by 
medical procedures, or that short-term pain does not matter. 
Chronic pains offer a different context for hypnosis. Cancer pain is usually caused by the 
tumor invasion or its pressure on nerves. Medical, surgical and radiological treatment of 
lesions are used to stop the disease and this often controls suffering directly, even if the 
short-term complementary use of analgesics may be useful. When medical management is 
not sufficient to durably prevent pain, complementary therapy is necessary, in order to 
avoid side-effects of long-term analgesic use (Deng, 2005) and frequent depression 
symptoms associated with both pain and analgesics. Pain complaints also significantly 
increase the burden for caregivers, whether relatives or professionals. 
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Self-hypnosis training plus group therapy was found to significantly reduce pain in women 
with metastatic breast cancer in the previously discribed trial of Spiegel et al. (Spiegel, 1983). 
A same strategy with breast cancer patients was tested over a four month period (Butler, 
2009): it significantly reduced chronic pain intensity over the period but not the frequency of 
pain episodes or the amount of constant pain. Syrjala (1992) confirmed some of these 
outcomes in a trial including 94 male or female adult patients diagnosed with leukemia, 
myelodysplasia or lymphoma, and suffering from persistent oral mucositis pain following 
bone marrow transplantation. Before hospitalization, training material (information on 
relaxation, deep breathing and audio-tapes) was presented through one-to-one interaction 
in two sessions. During hospitalization, patients were seen twice a week, one session 
including in-vivo relaxation and imagery. Patients were asked to practice daily. Patients of 
the control group recieved the standard treatment and an other control group was offered 
therapist support. After 5 weeks, pain was significantly alleviated by hypnosis. This trial 
tested also, in adjunction to hypnosis, a cognitive-behavioral coping skills training. This 
training showed no supplementary effect on pain measures.  
Controlled trial assessing the impact of hypnosis on chronic pain over the long run are 
lacking: therapeutic strategies covering longer intervals should be addressed in further 
studies. 
3.4 Treatment side-effects  
Typically, to meet treatment goals, antitumor drugs have to be toxic, surgery invasive and 
radiation aggressive. Targeted treatments such as monoclonal antibodies may not change 
this situation. Aside from pain, side-effects comprise a large set of symptoms: nausea, 
vomiting, fatigue, and neuropathy, and psychological disturbances more or less related to 
these symptoms. They may lower the patient’s therapeutic alliance with his physician 
and/or require dose reductions or delayed schedules, and thus limit the efficacy of 
treatment. Because these symptoms often appear before the treatment begins, it has been 
suggested that hypnosis could significantly remedy this problem. 
Nausea and vomiting are some of the most frequently encountered side-effects of 
chemotherapy. A universally effective anti-emetic medication remains elusive (Koeller, 
2002), although important advances have been made. Complementary approaches are 
therefore interesting, especially for anticipatory symptoms. Three trials tested this question 
using self-hypnosis (Syrjala, 1992; Jacknow, 1994; Hawkins, 1995) that patients were 
supposed to use before and during treatments, while the other one proposed tailored 
individual hypnosis (Zelter, 1991) including imaginative fantasy with suggestions (for 
example, holding or cuddling a pet). All these trials concerned pediatric cancer patients 
except for Syrjala (1992). Because of the small sample size of the four trials, a meta-analysis 
was conducted by Richardson (2007) who concluded that hypnotherapy significantly 
lessened symptoms. Overall, hypnosis was twice more efficient against nausea and/or 
vomiting symptoms than therapist contact and five times more than cognitive-behavioral 
management. Trials including pediatric patients contributed the most to the effect size but 
the other one including adults demonstrated no difference between intervention conditions.  
Fatigue is a frequent side-effect of cancer treatments, although the disease itself can 
concurrently be responsible for it. In one trial of radiotherapy, this symptom was stabilized 
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by cognitive-behavioral therapy plus hypnosis, while the control group showed a linear 
increase of fatigue scores over the same period (Montgomery, 2009). 
Hot-flushes in breast cancer patients are an underestimated symptom that affects almost 
80% of the women undergoing chemotherapy and 70% of those treated by hormonotherapy 
(Carpenter, 2001). It also concerns female patients and survivors of other cancer locations 
and is often associated with other physical symptoms including headaches, palpitations, or 
insomnia, and psychological difficulties such as irritation, or a sense of loss of control. Elkins 
(2008) included 60 females in remission of their breast cancer who suffered from frequent 
and/or intense hot-flushes. The five weekly sessions of hypnosis defined in the trial 
protocol consisted of "mental imagery and suggestions for relaxation; mental imagery for coolness; 
deepening hypnosis and dissociation from hot flashes; positive suggestions and imagery for the 
future". Results showed that hot-flushes frequency could be largely reduced by hypnosis (by 
68%) and that this reduction had a significant impact on overall quality of life and sleep.  
3.5 Management of digestive symptoms 
The digestive system and the treatment of related diseases and symptoms is a particular 
medical domain where hypnosis and psychosocial intervention can demonstrate their 
interest and at the same time shed new light on the interactions between mind and body. 
Thanks to Gershon’s findings (1965, 1998) on the importance of what he called “the second 
brain”, we now know that one of the most influential hormones on mood and depression 
(serotonin) is mainly secreted by enteric neurons, and that these neurons together form a 
network capable of autonomous responses. The digestive system is known to respond to 
psychological stress and emotions (Jones, 2006) although gastric troubles as ulcers have 
recently disappeared from the list of the psychosomatic diseases5. In 2008, Charioni et al. 
reviewed the literature testing the efficacy of hypnosis in the modulation of upper digestive 
motor and secretory function (more than 20 published reports). This did not take into 
account previously reported management against nausea and vomiting. Studies 
investigating the secretory function are not easy. They need nasogastric intubations in order 
to collect gastric secretion and sampling has to be made before and after the hypnosis 
intervention. Studies focusing on the gastric motor function needs less invasive procedures: 
real-time ultrasonography can measure with a good reliability gastric emptying rate using 
the diameter variation of the gastric antrum in the sagittal plane passing through the aorta. 
Suggestions must fit targeted funtions: to induce an increase of acid secretions in healthy 
volonteers, they are asked to visualize and eat the most delicious meal possible, while 
sensory aspects of the eating process, including food appearance, aroma, texture and taste, 
are explored and reinforced by hypnotist. On the opposite, the averting-food strategy uses 
intense imagery to divert one’s attention from eating. Imagery may concern lying on a 
beach, watching a sunset, or meeting a friend in a nice environment. To accelerate gastric 
motility, water flowing in a river or in a waterfall can be used; suggesting warmth in one 
hand and placing it over the epigastrium can associate suggestion of improved well being 
and gastric function mediated by the warmth of the hand.  
                                                 
5 Most often, peptic ulcers are caused by helicobacter pylori infection of the stomach and/or the use of 
NSAIDs, but about 20% of cases seem not related to either risk factor, and psychological factors are still 
suspected for them. Also, it is not impossible that psychological stress may alter gastric metabolism and 
thus favor the proliferation of the bacteria. 
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Reported investigations confirmed significant effects of hypnosis. The authors concluded 
that “hypnosis delivered in a single session by an expert therapist has been shown capable of 
modulating gastric secretion and accelerating gastric emptying in healthy volunteers. In addition, 
hypnosis has improved gastric emptying and epigastric sensations in severe functional dyspepsia. 
Small bowel transit may also be influenced by hypnosis” (Charioni, 2008 p.6282) As the delay of 
resumption of intestinal transit is of major importance in colorectal cancer surgery, hypnosis 
may be useful to reduce this delay and facilitate recovery. This field of research remains 
unexplored. 
4. Conclusion 
Numerous valuable works have been performed to test the use of hypnosis in oncology. 
Most of the results are encouraging and often durable: despite no definitive effect on the 
cancer prognosis itself has been objectivized, hypnosis has demonstrated its utility in many 
aspects of patient's well-being. The methodology used in these cross-sectional studies has 
largely improved over the past decades (Moyer, 2009), although some authors suggested 
that hypnotic protocols should be more accurately defined (Wild, 2004). Most published 
investigations were based on solution-oriented strategies: hypnosis was used to remedy one 
particular problem (pain, side-effects, hot flushes...). On the other hand, trials with more 
global goals (depression, quality of life) included hypnosis as a complementary method 
within a more general cognitive-educational approach. In fact, aside from a study of 
terminally ill cancer patients (Liossi, 2001), most studies used hypnosis in a very limited 
scope and/or as one of many psychological tools. Self-hypnosis has been used more often, 
and is usually taught during group sessions. This is regrettable, as outcomes seem better 
when sessions are adapted to the patient’s needs and desires (Syrjala, 1995) and only 
individual sessions enable such tailoring. Similarly, relaxation plus guided imagery 
represents only a small part of the various hypnosis techniques. Other techniques only 
available with tailored hypnosis enable the management of deeper psychological 
difficulties, and their resolution could result in a stronger effect on the cancer itself. 
Trials performed to test the effect of hypnosis on gastric system were more often done 
within personal sessions, but for experimental reasons, their goal was limited to localized 
somatic objectives. Therefore, no study really investigated with a correct methodology the 
impact of hypnosis on overall survival in cancer patients. 
Hypnosis remains an under-exploited therapy that has not revealed its full capacities 
against cancer. Although medical painful routine procedures and treatments side-effects are 
valuable targets for short interventions, researchers should be more audacious in the 
determination of goals. There are large domains that remain unexplored (immunity, 
genetics) and investigations in these domains could very well help understand how psyche 
interacts with soma (and vice-versa). Biological research always needs an accurate definition 
of goals, and parameters that objectivize changes in these goals. This does not imply that 
associated hypnotic protocols should also be reduced to a single induction type and/or a 
limited suggestions panel. On the other hand, when a person is taught self-hypnosis within 
a larger set of tailored hypnosis sessions, it provides him new skills to handle personally his 
pathology and/or other life problems. In such a strategy, the physical symptom could be 
considered as the starting point of an evolutive mental process that could benefit the whole 
personality of the patient. “For clinician, hypnosis is an opportunity to be inventive, spontaneous 
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and playful and to build a stronger therapeutic relationship with a patient while providing symptom 
relief” (Liossi, 2006, p.55). 
Hypnotisability, or susceptibility to hypnosis, is often supposed to limit the efficacy of 
hypnosis (Smith, 1996; Hawkins, 1998; Butler, 2009). Although Erickson claimed that 100% 
of normal people can be hypnotized and that most unsuccessful protocol failed because a 
too short time is reserved for the induction (Erickson, 1980; 1982), some studies have 
questioned if the power of suggestions coud vary with the subject's sensitivity to hypnotic 
induction. This question seems to have been solved thanks to Raz’s experiment with the 
stroop test6 where he demonstrated that hightly hypnotisable subjects were more likely to 
short-circuit neuronal networks managing conflicts than less hypnotisable subjects (Raz, 
2005). According to a large meta-analysis of 57 controlled trials testing hypnosis (Flammer, 
2003), the hypnotic susceptibility was responsible for about 20% of treatment outcomes. This 
percentage is not negligible but this means that 80% of hypnosis capacities depend on other 
parameters: this is a reassuring perspective. To our mind, hypnotisability should be tested if 
a rather fixed hypnotic protocol is used as sole intervention. With face-to-face tailored 
inductions, the hypnotist can adapt his suggestions to his subject's characteristics and 
generally obtain the trance depth or the receptivity he thinks necessary. 
As hypnosis requires only a few days training from physicians or nurses that want to use it 
in specialized contexts, some assume that this technique is rather simple and does not 
deserve any more effort and learning. Also, because psychological formation of physicians 
and nurses is rather limited, this can prevent them from engaging a deeper dialog with their 
patients and incite them to limit their support to what seems sufficient for their medical 
purpose. In such a situation, well defined and reduced hypnotic procedures may be felt 
protective: it holds off the threat of crisis that they could not keep under control. The 
separation between psychology and medicine raises another type of difficulty. For 
psychologists, symptoms management may represent a minor target compared to patients’ 
psychic well-being and evolution; but they can feel limited if they have to evaluate a 
physical symptom or make a decision about it. Is seems thus important that research teams 
include both types of practitioners, the physicians defining the primary endpoint 
(necessarily restricted if medical) and the psychologists/hypnotists the hypnotic strategy (as 
large as they wish, that is adaptable to patient's personality and needs) and possible 
secondary endpoints. 
Performed by skilled practitioners, hypnosis has a great potential mostly unexplored in 
oncology, especially as cancer represents for patients a major threat for life and since many 
patients are left without efficient medical solution. The consequences of this disease are so 
extensive that it exhausts psychological resources of individuals, and very often drives them 
to depression. Hypnosis has proven to be one of the most efficient psychological tools. It can 
contribute more rapidly than other psychosocial managements to biological changes. It does 
not expose patients to toxicities or side-effects. It can be delivered at very low expense to 
patients of almost any age. Hence, the limiting factor for research today is not means but 
ideas and priorities. When oncologists’ priority was the short-term survival, there was no 
                                                 
6The Stroop test presents the words red, blue, green and yellow in colored capital letters. The subject 
has to press a button identifying the real color of the letters. The difficulty is that sometimes the word 
RED is colored blue. Or the word YELLOW is colored green. 
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time left for psychological considerations. Nowadays, cancer often becomes a chronic 
disease (palliative treatments may last years). In curative situations, invasive surgeries have 
non negligible consequences (body image...) while complete remissions never totally discard 
the threat of a relapse: both situations considerably impact survivors’ psyche. There is 
therefore, facing cancer, a large place for psychosocial interventions and thus for hypnosis.  
As psychological risk factors of cancer are still under debate (depression, life events, coping 
styles...), research concerning hypnosis in cancer patients could very well bring new 
evidence about them too. Conversely, because it is easier to demonstrate changes at a 
biological level than at a psychological one, such research could help discriminate the best 
psychotherapeutic approaches from the others and give arguments to psychologists for a 
better integration into medicine and overall health management. 
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